Totient, an AI-driven drug discovery platform, raised $10 million in a seed funding round. Investors include Mission BioCapital, Sands Capital, Viva Biotech,…
Drug Discovery
-
-
OneThree Biotech, a biology-driven artificial intelligence platform that optimizes drug discovery and development, closed a $2.5 million seed funding round. The funding round…
-
BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, raised $22 million in a Series B…